In a Bank of America note published on Monday, the analyst argues that brand mail pharmacy margins can be 5-10% (and in many cases pharmacies are losing money on GLP-1 scripts), which are significantly lower than the 50% gross margins we estimate HIMS is capturing in its GLP-1 portfolio. It is unlikely that HIMS will follow Ros lead to partner with brand manufacturers, the analyst added, because HIMS differentiation and success is tied to its own brand equity for its products and selling branded pharmaceutical drugs would both hurt margins and cannibalize its core products. Diversifying Beyond the Major GLP-1 Drugs Hims could also look to broaden its weight loss offerings, leveraging its established telehealth platform to incorporate non-drug-based solutions

We have four laboratories working collaboratively on that same mission, to try to figure out how to restore vision either by the type of thing youre doing where youre restoring the cells that are already there, and enabling them to regrow their connection to the brain, or even in the idea of being able to put stem cells into the eye that could form new retinal ganglion cells, and again reconnect to the brain
It helps people reduce their body weight by controlling appetite, leading to fewer calories consumed
Eating slowly and chewing thoroughly reduces the amount of air swallowed and supports optimal digestion
It's time to fight fat from both directions.